Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD20 scFv-ELPs methods and therapeutics

CD20 scFv-ELPs methods and therapeutics

US Patent 10961317 · Granted Mar 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multimeric elastin-like polypeptides2025
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2025
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2025
Lym-1 and Lym-2 antibody compositions and improved car constructs2023
Lym-1 and Lym-2 antibody compositions and improved car constructs2023
Multimeric elastin-like polypeptides2022
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2022
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2022
Systems and methods for separating cannabis-derived compounds using chromatograp2022
Methods and therapeutics comprising ligand-targeted ELPs2022
Car t-cell therapy directed to LHR for the treatment of solid tumors2021
Car t-cell therapy directed to LHR for the treatment of solid tumors2021